SAB Biotherapeutics, Inc. (SABS)

NASDAQ: SABS · Real-Time Price · USD

3.980

+0.180 (4.74%)

At close: Dec 5, 2025, 4:00 PM EST

3.900

-0.080 (-2.01%)

After-hours: Dec 5, 2025, 7:57 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Immunotheraphies	2.24M	Log In	Log In	Log In
Immunotheraphies Growth	-90.63%	Log In	Log In	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
United States	2.24M	Log In	Log In	Log In
United States Growth	-90.63%	Log In	Log In	Log In